PHARMACOKINETICS AND SAFETY OF A LONG-ACTING SUBCUTANEOUS FORMULATION OF 2-METHOXYESTRADIOL (2ME) IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Tofovic, S. [1 ]
Jackson, E. [2 ,3 ]
Piche, C. [4 ]
机构：
[1] Univ Pittsburgh, Sch Med, Dept Med, Ctr Clin Pharmacol, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Med, Dept Med & Pharmacol, Ctr Clin Pharmacol, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Dept Biol Chem, Ctr Clin Pharmacol, Pittsburgh, PA USA
[4] PR Pharmaceut, Ft Collins, CO USA
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2009年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [1] Safety, tolerability and pharmacokinetics of rilpivirine following administration of a long-acting formulation in healthy volunteers
    Verloes, R.
    Deleu, S.
    Niemeijer, N.
    Crauwels, H.
    Meyvisch, P.
    Williams, P.
    HIV MEDICINE, 2015, 16 (08) : 477 - 484
  • [2] Association of 2-Methoxyestradiol (2ME) Plasma Levels with Clinical Severity Indices and Biomarkers of Preeclampsia
    Tripathi, Vartika
    Jaiswar, S. P.
    Deo, Sujata
    Shankhwar, Pushplata
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2019, 69 (SUPPL 2): : S122 - S127
  • [3] Association of 2-Methoxyestradiol (2ME) Plasma Levels with Clinical Severity Indices and Biomarkers of Preeclampsia
    Vartika Tripathi
    S. P. Jaiswar
    Sujata Deo
    Pushplata Shankhwar
    The Journal of Obstetrics and Gynecology of India, 2019, 69 : 122 - 127
  • [4] Single oral dose pharmacokinetics (PK) and safety of 2-methoxyestradiol (2ME2) in patients with solid tumors.
    Lakhani, NJ
    Sparreboom, A
    Venitz, J
    Dahut, W
    Figg, WD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 152S - 152S
  • [5] Pharmacokinetics, safety, and tolerability of albiglutide (Syncria®), a long-acting GLP-1 mimetic, in healthy volunteers
    Stewart, Murray W.
    Matthews, Jessica
    De Boever, Erika H.
    Dobbins, Robert L.
    Holland, Claire H.
    Hodge, Rebecca J.
    Gutierrez, Maria J.
    Walker, Susan E.
    Bush, Mark A.
    DIABETES, 2008, 57 : A155 - A155
  • [6] PHARMACOKINETICS OF A LONG-ACTING CHLORAMPHENICOL FORMULATION ADMINISTERED BY INTRAMUSCULAR AND SUBCUTANEOUS ROUTES IN CATTLE
    SANDERS, P
    GUILLOT, P
    MOUROT, D
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1988, 11 (02) : 183 - 190
  • [7] MRI examination of cabotegravir long-acting formulation depot kinetics in healthy adult volunteers
    Fuchs, E. J.
    Jucker, B. M.
    Lee, S.
    Damian, V.
    Galette, P.
    Janiczek, R.
    Solaiyappan, M.
    Jacobs, M. A.
    Macura, K. J.
    D'Amico, R.
    Shaik, J. Sadik
    Bakshi, K.
    Han, K.
    Ford, S. L.
    Margolis, D.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [8] Combination of 2-methoxyestradiol (2ME) and cyclophosphamide (CP) inhibits tumour progression in S-180 mouse tumour model system
    Mallick S.
    Chowdhury S.
    Banerjee A.
    Paul G.
    Banerjee S.N.
    The Nucleus, 2017, 60 (2) : 147 - 153
  • [9] The pharmacokinetics of a long-acting oxytetracycline formulation in healthy dogs and in dogs infected with Ehrlichia canis
    Kikuvi, GM
    Mitema, ES
    Buoro, IBJ
    VETERINARY RESEARCH COMMUNICATIONS, 2001, 25 (05) : 391 - 400
  • [10] The Pharmacokinetics of a Long-acting Oxytetracycline Formulation in Healthy Dogs and in Dogs Infected with Ehrlichia canis
    G.M. Kikuvi
    E.S. Mitema
    I.B.J. Buoro
    Veterinary Research Communications, 2001, 25 : 391 - 400
12345